Conversely, high PD-L1 expression in stromal cells was associated with shallower tumor depth and lower mortality rates, indicating a potential activated immune response that enhances immune-mediated tumor killing and inhibits tumor growth. This evidence concerns the gene CD274 and neoplasm.